Home » Topics » BioWorld Science

BioWorld Science
RSS

Redx Pharma nominates ROCK2 inhibitor RXC-007 as drug development candidate in fibrosis

Jan. 10, 2020

Inhibrx initiates phase I study of hexavalent OX40 agonist INBRX-106 for solid tumors

Jan. 10, 2020

Heptares Therapeutics discovers muscarinic M1 and/or M4 receptor agonists

Jan. 10, 2020

Drexel University synthesizes new HIV capsid assembly inhibitors

Jan. 10, 2020

Aduro BioTech identifies cGAS inhibitors

Jan. 10, 2020

Dana-Farber Cancer Institute discloses new EGFR inhibitors

Jan. 10, 2020

Novartis patents new compounds for leishmaniasis and trypanosomiasis

Jan. 10, 2020

Locus begins phase Ib trial of CRISPR Cas3-enhanced bacteriophage product LBP-EC01

Jan. 10, 2020

Phase III CONSTANT trial of Sci-B-Vac meets primary and secondary endpoints

Jan. 10, 2020

Regeneron announces phase II data for garetosmab in fibrodysplasia ossificans progressiva

Jan. 10, 2020

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...